Displaying 1 to 6 of 6 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Dec 2011 | Series F Initial investment. Round participant. Active |
|
|
Agios Pharmaceuticals Inc |
United States | N/A |
||
|
Armo BioSciences Inc Late-stage immuno-oncology company. |
1 Sep 2017 | Series C-1 Follow-on investment. Round participant. Active |
||
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Active |
|
|
|
Gloucester Pharmaceuticals Inc |
United States | N/A |
||
|
|
VentiRx Pharmaceuticals Inc |
United States | N/A |